Article
Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Apr 2020
Caliaro Oliver, Barbani Maria Teresa, Klenja Shkipe, Morfin Florence, Frobert Emilie, Gorgievski Meri, Steinlin-Schopfer Jacqueline, Suter-Riniker Franziska
Abstract excerpt
BACKGROUND: Acyclovir (ACV) is the most commonly used drug for herpes simplex virus (HSV) infection therapy. Prolonged antiviral therapy or prophylaxis in immunocompromised patients may promote the development of drug-resistant strains. Due to the high polymorphism in genes involved in drug resistance, phenotypic methods, although work-intensive, are still required to test drug susceptibility. Real-time cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
